Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,265.17 +40.22 (+0.06%) CMC Crypto 200
1,516.27 +27.72 (+1.86%)
Summit Therapeutics Inc. (SMMT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:30PM EDT. Market open.
| Previous close | 4.5400 |
| Open | 4.5200 |
| Bid | 4.3500 x 100 |
| Ask | 4.4400 x 100 |
| Day's range | 4.3500 - 4.6100 |
| 52-week range | 1.5000 - 5.3900 |
| Volume | |
| Avg. volume | 2,155,033 |
| Market cap | 3.078B |
| Beta (5Y monthly) | -1.13 |
| PE ratio (TTM) | 11.54 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
- GuruFocus.com
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
- Thomson Reuters StreetEvents
Q1 2024 Summit Therapeutics Inc Earnings Call
Q1 2024 Summit Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.